Our investigators and sites have the most experience conducting and enrolling ADRD clinical trials.
With each Project’s lead investigator, we build a strong collaborative team to design and conduct trials.
We lead the field in novel clinical trial designs, leveraging innovative cognitive, biomarker, neuroimaging outcomes, and data sharing.
Through centralization of resources and processes, we develop and utilize efficient solutions.
Our Inclusion, Diversity and Education in Alzheimer’s Disease – Clinical Trials (IDEA-CT) and Inclusive Recruitment committees promote inclusion and diversity in all ACTC activities.
Meet The Leadership Team
Paul Aisen, MD
Alzheimer’s Therapeutic Research Institute, USC
Reisa Sperling, MD
Brigham and Women’s Hospital Massachusetts General Hospital
Ron Petersen, MD, PhD
Department of Neurology Mayo Clinic, Rochester
Laurie Ryan, PhD
National Institute on Aging (NIA) National Institutes of Health (NIH)